Concepedia

Sean D. MacKnight

SD

Statistics

Publications

8

Citations

259

H-Index

8

Active since

2014

Affiliations

Analysis Group (United States)(Current)

Group for Research in Decision Analysis

Research Triangle Park Foundation

GlaxoSmithKline (United States)

University of Wisconsin–Madison

Sean D. MacKnight is an author at Analysis Group (United States) specializing in pharmacotherapy, combination inhaler therapy, and inhalation therapy.

ORCID

Publications per year

2014–2024

8

Publications

8

Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study

David M. Mannino, Michael Bogart, Benjamin Wu et al. · Respiratory Medicine · 2022 · 61 citations · Full text

, , +17

Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking

Graeme W. Carlile, Renaud Robert, Julie Goepp et al. · Journal of Cystic Fibrosis · 2014 · 48 citations · Full text

, , +11

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels

Alok A. Khorana, Nicole M. Kuderer, Keith R. McCrae et al. · Cancer Medicine · 2020 · 43 citations · Full text

, , +17

Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management

William W. Busse, Carl Abbott, Guillaume Germain et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 32 citations · Full text

, , +17

Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation

David M. Mannino, Michael Bogart, Guillaume Germain et al. · International Journal of COPD · 2022 · 29 citations · Full text

, , +17

1–5 of 8